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a  b  s  t  r  a  c  t
The  cattle  tick  Rhipicephalus  microplus  is one  of the  most  economically  damaging  livestock
ectoparasites,  and  its  widespread  resistance  to  acaricides  is  a considerable  challenge  to
its  control.  In this  scenario,  the  establishment  of resistant  cell  lines  is a useful  approach  to
understand  the  mechanisms  involved  in  the  development  of  acaricide  resistance,  to  identify
drug  resistance  markers,  and  to  develop  new  acaricides.  This study  describes  the  establish-
ment of an  ivermectin  (IVM)-resistant  R. microplus  embryonic  cell line,  BME26-IVM.  The
resistant  cells  were  obtained  after  the  exposure  of IVM-sensitive  BME26  cells  to increas-
ing doses  of IVM  in  a step-wise  manner,  starting  from  an  initial  non-toxic  concentration
of  0.5 g/mL IVM,  and  reaching  6 g/mL IVM  after  a 46-week  period.  BME26-IVM  cell line
was  4.5  times  more  resistant  to IVM  than  the  parental  BME26  cell line  (lethal  concentration
50  (LC50)  15.1  ± 1.6 g/mL  and  3.35  ±  0.09  g/mL,  respectively).  As  an  effort  to  determine
the  molecular  mechanisms  governing  resistance,  the  contribution  of  ATP-binding  cassette
(ABC) transporter  was  investigated.  Increased  expression  levels  of  ABC  transporter  genes
were found  in IVM-treated  cells,  and  resistance  to IVM  was  signiﬁcantly  reduced  by co-
incubation  with  5 M cyclosporine  A (CsA),  an  ABC  transporter  inhibitor,  suggesting  the
involvement  of  these  proteins  in IVM-resistance.  These  results  are  similar  to  those  already
described  in  IVM-resistant  tick  populations,  and  suggest  that  similar  resistance  mecha-
nisms  are  involved  in vitro
are  involved  in IVM  resist
to study  acaricide  resistan
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ance  and  support  the  use  of  BME26-IVM  as  an  in  vitro  approach
ce  mechanisms.
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. Introduction
Rhipicephalus microplus is one of the most deleterious
attle ectoparasites worldwide. In addition to the direct
ffects of R. microplus infestation on milk, meat, and leather
roduction, this tick species is the vector for the infec-
ious agents that cause bovine babesiosis and anaplasmosis
Jonsson, 2006; Jonsson et al., 2008).
The development of chemicals with acaricidal prop-
rties favored the adoption of these substances as the
ain method of cattle tick control (Guerrero et al., 2012).
owever, R. microplus has become resistant to most
ommercially available acaricides, thereby reducing the
ffectiveness of tick control (Klafke et al., 2006; Castro-
aner et al., 2011; Guerrero et al., 2012).
Macrocyclic lactones, such as ivermectin (IVM), are
ncreasingly used to control endo- and ectoparasites,
ncluding R. microplus (Fox, 2006; Guerrero et al., 2012).
VM activates glutamate-gated chloride ion channels in
nvertebrate nerve and muscle cells, causing the paralysis
f peripheral motor function and death of the organism
Fox, 2006). However, recent reports concerning IVM-
esistant cattle tick populations in Brazil (Martins and
urlong, 2001; Klafke et al., 2006), in Mexico (Perez-Cogollo
t al., 2010), and in Uruguay (Castro-Janer et al., 2011)
ave emphasized the importance of understanding the
echanisms of acaricide resistance to improve tick control
ethods.
Previous studies have associated ATP-binding cassette
ABC) transporters with drug resistance in nematodes
James and Davey, 2009), arthropods (Pohl et al., 2011;
tsumi et al., 2012), and cancer cells (Gillet et al., 2007). ABC
ransporters are integral membrane proteins expressed
n all organisms, and are essential for several physiolog-
cal processes (Holland and Blight, 1999). Certain ABC
ransporters are involved in the cellular detoxiﬁcation
f xenobiotics by pumping the drugs across membranes
efore they can reach their target site (Szakács et al., 2008).
BC transporters are able to transport drugs with diverse
tructures and functions, conferring a cellular phenotype
ermed “multidrug resistance” (Higgins, 2007).
Recently, we  demonstrated the association of ABC trans-
orters with macrocyclic lactones (IVM, abamectin and
oxidectin) and organophosphate resistance (Pohl et al.,
011, 2012) in R. microplus.  The results of these studies
inked the participation of ABC transporters to drug resis-
ance, via a multidrug detoxiﬁcation mechanism.
Currently, the routine detection of acaricide resistance
s based on bioassay techniques, such as the larval packet
est and the adult immersion test; however, bioassays
re time-consuming and laborious (Drummond et al.,
973; Klafke et al., 2006). The development of more sen-
itive diagnostic methods based on molecular biology
ethodologies is a convenient alternative, such as the
llele-speciﬁc PCR assay to detect a mutation in the para-
ype sodium channel gene, which identiﬁes pyrethroid
esistance in ticks (Guerrero et al., 2001). However, the
evelopment of more sensitive methods relies on under-
tanding the mechanisms involved in resistance, which in
urn depends on studying tick populations in which acari-
ide resistance has already been established in the ﬁeld.logy 204 (2014) 316–322 317
In this sense, in vitro cell culture is an attractive alter-
native, because the experimental parameters can be more
easily controlled, thereby reducing variability between
experiments. Additionally, cell culture is a cost-effective
approach to investigate drug resistance mechanisms, even
before resistance has been established in ﬁeld populations.
Moreover, cell culture experiments allow the rapid screen-
ing of new drugs under development. For example, the
selection of cancer cell lines for resistance to cytotoxic
drugs has been a key element in the identiﬁcation of muta-
tions responsible for drug resistance (Edwards et al., 2008).
Considering the importance of understanding the
mechanisms of drug resistance to improve the detection
and prevention of acaricide-resistant tick populations, we
questioned if an acaracide resistant tick cell line selected
in vitro has similar resistance mechanisms to those gov-
erning acaricide resistance in vivo, which would be a useful
approach to study acaricide resistance. In this study, we
report the in vitro selection of an IVM-resistant R. microplus
cell line derived from the BME26 cell line (Esteves et al.,
2008), and demonstrate the involvement of ABC trans-
porters in the process of IVM resistance in these cells.
2. Materials and methods
2.1. Cell lines and maintenance
An IVM-resistant cell line (BME26-IVM) was derived
from drug-sensitive BME26 cells, which were originally
isolated from R. microplus embryos (Esteves et al., 2008).
The cell lines were grown as adherent monolayers in
complete medium, as described by Esteves et al. (2008) (L-
15B300 medium supplemented with 5% heat-inactivated
Fetal Bovine Serum (FBS) (Gibco), 10% Tryptose Phos-
phate Broth (TPB) (BD), penicillin (100 U/mL), streptomycin
(100 mg/mL) (Gibco), and 0.1% bovine lipoprotein concen-
trate (ICN), pH 7.2). For BME26-IVM cells, the complete
medium was supplemented with IVM (6 g/mL) (Sigma)
diluted from a stock solution of 2 mg/mL  IVM in 50%
methanol. The cells were grown at 34 ◦C in 25 cm2 plastic
ﬂasks (Falcon) in 5 mL of the medium, which was  replaced
every 7 days.
2.2. Establishment of IVM-resistant cell line
The BME26-IVM cells were derived from the parental
BME26 cells (23rd passage) by continuous exposure to
increasing concentrations of IVM in a step-wise manner.
Every 4 weeks, the cells were harvested with a cell scraper
and transferred into a new plastic ﬂask containing the same
concentration of IVM or into a ﬂask containing a higher con-
centration of the drug. Starting from an initial non-toxic
concentration of 0.5 g/mL IVM, the cells were eventually
able to grow in the presence of 6 g/mL IVM after 46 weeks
of selection.
2.3. Growth curve and doubling time determinationBME26 (40th passage) or BME26-IVM (38th passage)
cells were seeded (5 × 105 cells) in 25 cm2 plastic ﬂasks
in triplicate and cultured in 5 mL  of complete medium.
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After a 4 h incubation period, the medium was replaced
with fresh complete medium or complete medium sup-
plemented with IVM. Every 7 days, viable cell density was
determined by counting trypan blue (Sigma)-stained cells
(0.04% trypan blue in phosphate buffered saline (145 mM
NaCl, 80 mM Na2HPO4, and 20 mM NaH2PO4)) using a
Neubauer hemocytometer (Esteves et al., 2008) to generate
a growth curve over a 28-day culture period.
The cell doubling-times (dt)  were calculated during
exponential growth (7th–28th days) using the equation
dt = ln(2)/n, where n = [ln (ﬁnal number of cells) − ln (initial
number of cells)]/[(ﬁnal time) − (initial time)].
2.4. Cytotoxicity assay
The tetrazolium dye MTT  (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide) was used to
evaluate the cytotoxicity of different IVM concentrations
in the absence or presence of cyclosporine A (CsA), an ABC
transporter inhibitor (Choi, 2005). BME26 (41st passage)
or BME26-IVM (39th passage) cells were seeded (1 × 106
cells) in 25 cm2 plastic ﬂasks in triplicate and incubated
in complete medium. After a 4-h incubation period, the
medium was replaced with fresh complete medium with-
out IVM or with medium supplemented with IVM at a
concentration of 1, 3, 6 or 9 g/mL, with or without 5 M
CsA (predetermined non-toxic dose). After a 9-day incuba-
tion period, the cells were harvested with a cell scraper, and
1 mL  of the cell suspension in each ﬂask was transferred in
triplicate to a 24-well plate (Nunc), and incubated for 2 h to
sediment the cells on the plate. The medium was replaced
with 0.5 mL  of MTT  solution (0.5 mg/mL  in cell medium),
and the cells were incubated for an extra 90-min period at
34 ◦C. The MTT  solution was removed and replaced with
0.5 mL  of 0.002% HCl in isopropanol. The plate was  fur-
ther incubated for 5 min  at room temperature to dissolve
the dark blue formazan crystals, and 100 L of solution
was transferred to a 96-well plate. Optical density values
were measured at a wavelength of 570 nm using a multi-
well scanning spectrophotometer (Labsystems iEMS). The
percentage of viable cells treated with IVM or IVM + CsA
was normalized to the untreated cells, which were consid-
ered to be 100% viable. The lethal concentration 50 (LC50),
deﬁned as the concentration necessary to reduce cell sur-
vival by 50%, was calculated from dose-response curves in
the presence or absence of CsA. The resistance ratio (RR)
was estimated by dividing the LC50 of the BME26-IVM cells
Table 1
Primers used in the relative quantiﬁcation of R. microplus ABC transporter mRNA
Gene NCBI accession no. Primer Sequence 5′–3
40S ribosomal EW679928 Forward ACG ACC GAT
Reverse TGA GGC GAA
RmABCC1 JN098447 Forward GAC ACC ATT
Reverse GCC CTG CTC 
RmABCC2 JN098448 Forward CGC GGG ACC
Reverse GGT AGC TCG
RmABCB7 JX170903 Forward AGTGATGGCA
Reverse CATTCTCCTGG
RmABCB10 JN098446 Forward GCC GCA GTT
Reverse ACG TCC GCT logy 204 (2014) 316–322
by that of the parental BME26 cells. The fold-reversal factor
was  estimated by dividing the LC50 of the cell line treated
with IVM and without CsA by that of the cell line treated
with both IVM and CsA.
2.5. Light microscopy
Cells were collected by scraping and were centrifuged
onto microscope slides at 1000 × g for 5 min  using a cyto-
centrifuge (Fanem). The cells were air-dried, stained with
Panoptico (Newprov) stain, and observed under oil immer-
sion using a light microscope at 1000× magniﬁcation.
2.6. Reverse transcription quantitative PCR (RT-qPCR)
To evaluate the mRNA expression of ABC transporters,
BME26 and BME26-IVM cells were incubated for 9 days
in complete medium alone or complete medium with 6
or 9 g/mL IVM. The cells were then collected by scrap-
ing and centrifuged at 5000 × g for 5 min. Total RNA was
extracted from the cells using TRIzol® reagent (Invit-
rogen) following the manufacturer’s recommendations.
The RNA quantity was estimated spectrophotometrically
at 260 nm using a NanoDrop 1000 instrument (Thermo
Fisher Scientiﬁc). One microgram of total RNA was treated
with DNase I (Invitrogen) and reverse-transcribed using
the High-Capacity cDNA Reverse Transcription Kit with
random primers, according to the manufacturer’s recom-
mendations (Applied Biosystems). RT-qPCR was  performed
to quantify the mRNA of ABC transporters using the Quan-
timix Easy SYBR Green Ampliﬁcation Kit (Biotools) in
a Mastercycler® ep realplex real-time PCR instrument
(Eppendorf). The speciﬁc primers designed for gene ampli-
ﬁcation are listed in Table 1. Gene ampliﬁcation of the
40-S tick protein was  used for normalization (Pohl et al.,
2008). The cycling parameters were as follows: 10 min  at
95 ◦C followed by 40 cycles of denaturation at 95 ◦C for 15 s,
annealing at 60 ◦C for 15 s, and extension at 72 ◦C for 20 s.
To conﬁrm primer speciﬁcity to produce a single ampliﬁca-
tion product, a melting curve analysis was  performed using
the default parameters of the instrument, and represen-
tative products from the RT-qPCR were electrophoresed.
Primer efﬁciency was  measured with 2-fold serially diluted
cDNA, and for the transcription analyses, 300 ng of cDNA
was  added to each reaction. The relative expression ratio
of ABC transporter genes was calculated according to the
mathematical model described by Pfafﬂ (2001) using the
s by RT-qPCR.
′ Tm Amplicon size (bp)
 GGC TAC CTC CTC CGC 59.1 106
 CCT GGT TGT GCT GAG CG 59.2
 CAC CGA GAG TTC AGT AGC AC 61.9 120
CAC TAT TTC GCC ACC 64.2
 TTC TGA AGC 58.9 84
 GTA TAG GGC TAG ACG 59.8
GAGTGTGTGAACGG 59.9 109
TGGGCTTGATGC 61.4
 GTC ACT TGT TGG TTT G 61.3 95
GCC ACT TGC CTC 64.9
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Fig. 1. BME26 cell growth in the presence of increasing ivermectin (IVM)
concentrations. Cells were cultured without or with IVM at a concentra-
































Fig. 2. Effects of ivermectin (IVM) on cell growth. (A) Cells were cultured
in  medium without (−IVM) or with (+IVM) 6 g/mL IVM. Viable cells were
counted every 7 days over a 28-day culture period. All measurements
are expressed as the mean ± S.D., n = 3. The asterisks (*) denote signiﬁ-
cant differences (p ≤ 0.05). (B) Panoptico-stained BME26 and BME26-IVMays over a 28-day culture period. All measurements are expressed as the
ean ± S.D., n = 3. The asterisks (*) denote signiﬁcant differences from the
ontrol (p ≤ 0.05).
elative Expression Software Tool (REST-MCS©, version 2)
Pfafﬂ et al., 2002). Each analysis was conducted on biolog-
cal triplicates.
.7. Statistical analyses
The statistical signiﬁcance of the cytotoxicity and
oubling-time assays was analyzed by two-way ANOVA
nd Bonferroni tests. The statistical signiﬁcance of RT-qPCR
esults was analyzed by one-way ANOVA and Tukey’s tests.
he results are expressed as the mean ± S.D. p values ≤0.05
ere considered to be statistically signiﬁcant.
. Results
.1. Selection of BME26-IVM cells
Prior to the selection of IVM-resistant cells, the effect
f IVM on the growth of the parental BME26 cells was
nalyzed (Fig. 1). BME26 cells were incubated at different
oncentrations of IVM over a 28-day period. No signiﬁcant
ifference was observed in the doubling-time of non-IVM-
xposed cells (13 ± 0.4 days), compared with that of cells
reated with 0.5 g/mL IVM (11 ± 2.5 days). BME26 cells
reated with 2.5 g/mL IVM grew relatively more slowly,
ith a signiﬁcantly longer doubling-time (30 ± 0.3 days).
hen treated with higher IVM doses (12.5 or 62.5 g/mL),
he cells did not survive (Fig. 1). Cell viability was not
ffected by methanol (IVM solvent) (data not shown).
ased on these data, an IVM-resistant cell line (BME26-
VM) was established after 46 weeks by exposing the
arental BME26 cells to increasing IVM concentrations,
tarting at 0.5 g/mL and ultimately reaching 6 g/mL..2. Characterization of BME26-IVM cells
The growth rates of the drug-sensitive parental cells
BME26) and the IVM-resistant cells (BME26-IVM) werecells after a 14-day incubation period in medium without (−IVM) or with
(+IVM) 6 g/mL IVM, as observed by light microscopy (10× 1000× mag-
niﬁcation).
compared. Both had the same doubling time, 16 ± 1 days,
when grown in medium without IVM (Fig. 2A, – IVM).
The BME26-IVM cells incubated with 6 g/mL IVM had a
doubling time of 12 ± 1 days, which was not signiﬁcantly
different from that of the cells incubated without IVM.
However, the BME26 cells incubated with 6 g/mL IVM had
a much longer doubling time, 34 ± 4 days (Fig. 2A, +IVM),
indicating that IVM had a cytotoxic effect on the drug-
sensitive cells. Due to the cytotoxicity of IVM, the BME26
cells became more vacuolated (Fig. 2B) than the BME26-
IVM cells, which retained a similar morphology to that of
the untreated cells (Fig. 2B).
3.3. IVM resistance determination and evaluation of
involvement of ABC transporters in IVM resistance
To evaluate IVM resistance, the viabilities of the BME26
and BME26-IVM cell lines were examined after exposure to
different concentrations of IVM in the presence or absence
of the ABC transporters inhibitor CsA (Fig. 3A). The cel-
lular viability of BME26 cells was  signiﬁcantly reduced,
compared with that of BME26-IVM cells after treatment
with increasing IVM concentrations (Fig. 3A). The LC50 of
BME26 cells (3.35 ± 0.09 g/mL) was  signiﬁcantly lower
than that of BME26-IVM cells (15.1 ± 1.6 g/mL) (Fig. 3B),
demonstrating that the BME26-IVM cells were 4.5 times
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Fig. 3. Ivermectin (IVM) resistance determination and the effects of
cyclosporin A (CsA) on IVM toxicity. Cells were incubated in complete
medium supplemented without or with IVM at a concentration of 1, 3, 6
or  9 g/mL in the absence or presence of 5 M CsA. After a 9-day incu-
bation period, the cell viability was  determined. (A) The percentage of
viable cells is expressed as the percentage of surviving cells in medium
without IVM (100% cell viability). All measurements are expressed as the
mean ± S.D., n = 3. The asterisks (*) denote signiﬁcant differences from
BME26-IVM (p ≤ 0.05). (B) The LC50 values for BME26 and BME26-IVM
cells in the presence or absence of the ABC transporter inhibitor CsA. The
different superscripted letters following the values indicate statistical sig-
niﬁcance (p ≤ 0.05). A The RR was estimated by dividing the LC50 of the
Fig. 4. Relative transcription levels of ABC transporter genes in BME26
and BME26-IVM cells cultured in medium without IVM or medium with
6  g/mL or 9 g/mL IVM. After a 9-day incubation period, RNA was
extracted from these cells, and ABC transporters mRNA was analyzed
by RT-qPCR. The data represent the mean ± S.D. of three independentBME26-IVM cells by that of the parental BME26 cells. B The fold-reversal
factor was estimated by dividing the LC50 of the cell line treated with IVM
and without CsA by that of the cell line treated with both IVM and CsA.
more resistant to IVM than the BME26 cells. The cellu-
lar viability of BME26-IVM cells co-incubated with CsA
was signiﬁcantly reduced compared with that of BME26-
IVM cells not exposed to CsA (Fig. 3A). The LC50 of the
BME26-IVM cells co-incubated with CsA was signiﬁcantly
decreased compared with the LC50 of the cells not exposed
to CsA (15.10 ± 1.6 g/mL and 8.42 ± 0.83 g/mL, respec-
tively), indicating a reduction in the resistance to IVM by
a factor of 1.79 (Fig. 3B). In contrast, CsA had no effect on
BME26 cells (Fig. 3A and B).
3.4. Expression of ABC transporters in IVM-resistant cells
Because ABC transporters are involved in IVM resis-
tance, the transcription levels of ABC transporters were
investigated. The ABC transporters expression proﬁles
(RmABCC1, RmABCC2, RmABCB7,  and RmABCB10) were
determined by RT-qPCR analysis of BME26 and BME26-IVM
cells in the presence or absence of IVM. As shown in Fig. 4,
RmABCB10 gene expression was signiﬁcantly increased in
BME26-IVM cells exposed to IVM compared with untreated
cells. A signiﬁcant increase in RmABCC1 expression was
also observed in both BME26 and BME26-IVM cells treated
with 9 g/mL IVM. Whereas RmABCB7 was only upregu-
lated in BME26 cells exposed to IVM, the expression levels
of RmABCC2 were not signiﬁcantly different across all treat-
ments. These results demonstrate that ABC transporters are
involved in the cellular response to IVM exposure.experiments, normalized to 40-S transcript levels. The letter ‘a’ denotes
signiﬁcant differences (p ≤ 0.05) from BME26 cells (−IVM), and ‘b’ denotes
signiﬁcant differences (p ≤ 0.05) compared with all treatments.
4. Discussion
In the present study, an IVM-resistant cell line was
selected to elucidate the metabolic basis of IVM resis-
tance in ticks. This cell line was obtained after exposing
the embryonic cell line BME26 to increasing but non-lethal
doses of IVM. The BME26-IVM cell line was 4.5 times more
resistant than the parental BME26 cells, an RR similar to
that observed in ﬁeld tick populations resistant to IVM
(Pohl et al., 2011).
Cell lines derived from human cancer have been used
to identify genetic alterations responsible for drug resis-
tance (Gillet et al., 2007; Wind and Holen, 2011). In
addition, previous studies have also shown that insect-
and tick-derived cell lines are useful tools for eval-
uating the molecular mechanisms of drug resistance.
Joussen et al. (2008) showed that the gene Cyp6g1, a
cytochrome P450 monooxygenase, is overexpressed in cul-
tured cells from Nicotiana tabacum, which metabolizes
the insecticides DDT (dichlorodiphenyltrichloroethane)
and imidacloprid. This same gene is overexpressed in
Drosophila melanogaster strains resistant to a wide range of
insecticides, including DDT and imidacloprid (Daborn et al.,
2001). Similar results were observed for R. microplus, as
both organophosphate-resistant cell lines (Cossio-Bayugar
et al., 2002) and organophosphate-resistant tick pop-
ulations showed increased levels of esterase activity
(Rosario-Cruz et al., 1997). These reports showed that
similar phenotypes are observed in vivo and in vitro,
thus supporting the concept of the development of drug-
resistant cell lines as a useful tool to study the mechanisms
of cellular drug resistance.
Over the past 30 years, in vitro studies have led to the
identiﬁcation of approximately 400 genes whose expres-
sion levels affect the response to chemotherapy in human
cancer cells (Gillet and Gottesman, 2010). Among those
genes, the ABC transporters, a superfamily of 48 highly
homologous members classiﬁed into seven subfamilies,
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hereby affecting the bioavailability and effectiveness of
he drugs (Szakács et al., 2006; Gillet et al., 2007).
The expression levels of ABC transporters has also
een associated with drug resistance in arthropods and
ematodes. The overexpression of ABC transporters was
ssociated with IVM resistance in Haemonchus contortus
Xu et al., 1998), Caenorhabditis elegans (James and Davey,
009), Pediculus humanus humanus (Yoon et al., 2011), Sar-
optes scabiei (Mounsey et al., 2010), and R. microplus (Pohl
t al., 2011). The inﬂuence of IVM on the expression of
BC transporters has also been investigated in cultured
ells. Ménez et al. (2012) showed that IVM induced a time-
nd concentration-dependent upregulation of the mRNA
evels of two ABC transporters in cultured mouse hep-
tocytes. Luo et al. (2013) also found that avermectins,
6-membered macrocyclic lactone derivatives that include
VM, induced an upregulation in protein level of an ABC
ransporter in D. melanogaster S2 cells.
Corroborating these reports, our results showed that
mABCC1, RmABCB7,  and RmABCB10 were overexpressed
n cells treated with IVM. Furthermore, the incuba-
ion of BME26-IVM cells with a known ABC transporter
nhibitor, CsA, partly reversed the resistance increasing
he IVM toxicity. Taken together, these results suggest
hat ABC transporter proteins play a signiﬁcant role in
he development of resistance to IVM in this cell line.
evertheless, because the reversal of resistance was only
artial with the ABC transporter inhibitor, our results sug-
est that IVM resistance in R. microplus is multifactorial.
he roles of detoxiﬁcation enzymes, such as esterases,
ytochrome P450 monooxygenases, and glutathione-S-
ransferases should also be considered, although these
oles have not yet been shown with respect to IVM resis-
ance in R. microplus.
In  a previous study, we reported that the inhibitor CsA
ncreased IVM toxicity in resistant tick larvae and adults.
he same ABC transporter gene that was shown to be
pregulated in the present study (RmABCB10) has also been
hown to be upregulated in an IVM-resistant tick popula-
ion (Pohl et al., 2011).
. Conclusion
Our results support the idea that similar biochemical
echanisms of IVM drug resistance are involved in vitro
nd in vivo, thus validating the use of the IVM-resistant
ME26-IVM cell line to study IVM resistance development
n the tick. Moreover, in vitro assays allow the experimen-
al parameters to be rigorously controlled, thus reducing
ariability, which is often difﬁcult to achieve in a bioas-
ay. In conclusion, the establishment of acaricide-resistant
ell line is useful for the study of the mechanisms of resis-
ance to IVM and other drugs, which remain to be better
haracterized.ompeting interests
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